Dishman Carbogen Amcis Ltd
NSE:DCAL

Watchlist Manager
Dishman Carbogen Amcis Ltd Logo
Dishman Carbogen Amcis Ltd
NSE:DCAL
Watchlist
Price: 207.45 INR 2.16% Market Closed
Market Cap: ₹32.5B

Operating Margin

9.6%
Current
Improving
by 6.5%
vs 3-y average of 3.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
9.6%
=
Operating Income
₹2.7B
/
Revenue
₹27.6B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
9.6%
=
Operating Income
₹2.7B
/
Revenue
₹27.6B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Dishman Carbogen Amcis Ltd
NSE:DCAL
32.5B INR
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.2B USD
Loading...
US
Danaher Corp
NYSE:DHR
166.4B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
82.9T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
38.5B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
41.4B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.7B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.7B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
29.3B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.9B EUR
Loading...

Market Distribution

In line with most companies in India
Percentile
59th
Based on 5 437 companies
59th percentile
9.6%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Dishman Carbogen Amcis Ltd
Glance View

Dishman Carbogen Amcis Ltd. is a manufacturing company, which engages in the provision of outsourcing services for the pharmaceutical industry. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2017-09-21. The firm's segments include CRAMS and Vitamin - D, Bulk Drugs, Quats, Specialty Chemicals and traded goods. The firm assists pharma companies through various stages of drug development from process research and development to late-stage clinical and commercial manufacturing facilities, along with the supply of active pharmaceutical ingredients (APIs) and intermediates. The firm has manufacturing and research facilities in India, Switzerland, France, Netherlands, United Kingdom and China. The firm's subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., Dishman Carbogen Amcis (Singapore) Pte. Ltd., CARBOGEN AMCIS Holding AG and Dishman Biotech Ltd.

DCAL Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
9.6%
=
Operating Income
₹2.7B
/
Revenue
₹27.6B
What is Dishman Carbogen Amcis Ltd's current Operating Margin?

The current Operating Margin for Dishman Carbogen Amcis Ltd is 9.6%, which is above its 3-year median of 3.2%.

How has Operating Margin changed over time?

Over the last 3 years, Dishman Carbogen Amcis Ltd’s Operating Margin has increased from 0.4% to 9.6%. During this period, it reached a low of -4% on Jun 30, 2024 and a high of 9.6% on Sep 30, 2025.

Back to Top